在费城的亚裔美国社区中,描述肺癌负担
Christine S Shusted1, Julie A Barta1, Anh Nguyen2
1Division of Pulmonary and Critical Care Medicine, The Jane and Leonard Korman Respiratory Institute at Thomas Jefferson University, Philadelphia, PA, USA.
Journal of racial and ethnic health disparities
|August 4, 2023
概括
费城亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲 亚洲印度人和韩国人显示出更高的晚期疾病发病率,尽管亚洲社区的整体死亡率较低.
科学领域:
- 在瘤学瘤学.
- 公共卫生 公共卫生
- 流行病学 流行病学
背景情况:
- 肺癌 (LC) 是亚裔美国人癌症死亡的主要原因.
- 在不同的亚洲种族小组中,LC发病率和死亡率存在显著差异.
- 了解这些变异对于有针对性的公共卫生干预至关重要.
研究的目的:
- 描述费城人口普查区 (CTs) 在不同种族/族群中肺癌 (LC) 的负担和差异.
- 调查亚洲亚组中LC发病率,诊断阶段和死亡率的变化.
- 检查亚洲社区中社会经济因素与LC之间的关联.
主要方法:
- 利用了费城居民的宾夕法尼亚癌症登记数据集 (N=11,865).
- 地理编码的患者地址到人口普查通道 (CT) 层面,以与美国人口普查数据进行链接.
- 分析了跨种族/族群和亚洲子组的LC发病率,阶段,死亡率和人口统计因素.
主要成果:
- 亚洲患者被诊断出更晚期的LC,但生存率更高.
- 亚洲,印度和韩国亚组显示出远期LC和LC特异性死亡率的最高流行率.
- 亚洲人口较多的人口普查区表现出较低的社会经济地位和较高的烟草零售商密度.
结论:
- 费城亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲亚洲.
- 需要针对高风险的种族和民族群体进行有针对性的研究和干预,包括特定的亚洲亚群.
- 社会经济因素和环境暴露可能导致亚洲社区的LC差异.
相关概念视频
Statistical Methods for Analyzing Epidemiological Data
411
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
411
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.8K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.8K
Other Pulmonary Disorders
872
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
872
COPD: Pathogenesis and Clinical Features
344
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
344
Lung Capacity
50.7K
The air in the lungs is measured in volumes and capacities. Lung volume measures reflect the amount of air taken in, released, or left over after a lung function, like a single inhalation. Lung capacity measures are sums of two or more lung volume measures.
50.7K


